Both telemedicine and community screening for diabetic retinopathy (DR) in rural and urban settings are cost-effective in China, and telemedicine screening programs are more cost-effective, according to a study led by a group of ophthalmologists and economists.
The results were published in Health Data Science, a Science Partner Journal.